PG
Q4 2026 EPS Estimate
$1.89
Oct 23, 2026 · Reports before open
Revenue Estimate
$22.72B
FY2027E EPS$7.00
FY2028E EPS$7.40

Analyst Sentiment

Wall St. Consensus
Buy
26 analysts·High coverage
64
Score
15 Buy (58%)11 Hold (42%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1558%
Hold
1142%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$142.00
-1.8%
Consensus
$162.00
+12.1%
Bull
$172.00
+19.0%
12-Month Target Range26 analysts
$142.00$162.00$172.00
Current $144.55Consensus
Current Price
$144.55
Upside to Consensus
$17.45

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+1.79%
EPS+1.78%
FY2028
Rev+2.87%
EPS+5.82%
FY2029
Rev+3.53%
EPS+5.20%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027EFY2028EFY2029EFY2030EFY2031E
Revenue Avg$88.71B$91.25B$94.47B$96.89B$94.16B
Low$88.26B$90.07B$91.20B$95.42B$92.73B
High$89.14B$94.16B$96.02B$98.80B$96.02B
EBITDA Avg$23.54B$24.22B$25.07B$25.72B$24.99B
Low$23.42B$23.91B$24.21B$25.33B$24.61B
High$23.66B$24.99B$25.49B$26.22B$25.49B
EBIT Avg$23.67B$24.35B$25.21B$25.85B$25.13B
Low$23.55B$24.04B$24.34B$25.46B$24.74B
High$23.79B$25.13B$25.62B$26.36B$25.62B
Net Income Avg$16.83B$17.96B$18.50B$19.01B$16.42B
Low$16.69B$17.82B$17.07B$18.64B$16.10B
High$17.51B$18.11B$19.86B$19.50B$16.85B
EPS Avg$7.00$7.40$7.79$7.85$6.78
Low$6.89$7.35$7.05$7.69$6.65
High$7.23$7.47$8.20$8.05$6.95
Analysts (Rev / EPS)16 / 1517 / 1313 / 511 / 35 / 4
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$22.72B$22.67B$21.55B$21.71B$23.35B$23.30B$22.17B$22.36B
Low$22.39B$22.08B$21.22B$21.38B$22.99B$22.94B$21.83B$22.02B
High$23.02B$22.92B$21.75B$21.91B$23.56B$23.51B$22.37B$22.57B
EBITDA Avg$6.03B$6.02B$5.72B$5.76B$6.20B$6.18B$5.88B$5.94B
Low$5.94B$5.86B$5.63B$5.67B$6.10B$6.09B$5.79B$5.85B
High$6.11B$6.08B$5.77B$5.82B$6.25B$6.24B$5.94B$5.99B
EBIT Avg$6.06B$6.05B$5.75B$5.79B$6.23B$6.22B$5.92B$5.97B
Low$5.98B$5.89B$5.66B$5.70B$6.13B$6.12B$5.82B$5.88B
High$6.14B$6.12B$5.80B$5.85B$6.29B$6.27B$5.97B$6.02B
Net Income Avg$4.55B$4.56B$4.02B$3.78B$4.83B$4.82B$4.27B$4.02B
Low$4.38B$4.49B$3.94B$3.71B$4.73B$4.73B$4.19B$3.94B
High$4.79B$4.68B$4.07B$3.83B$4.88B$4.88B$4.32B$4.06B
EPS Avg$1.88$1.88$1.66$1.56$1.99$1.99$1.76$1.66
Low$1.81$1.85$1.63$1.53$1.95$1.95$1.73$1.62
High$1.98$1.93$1.68$1.58$2.02$2.01$1.78$1.68
Analysts (Rev / EPS)11 / 1411 / 145 / 85 / 68 / 65 / 124 / 135 / 7

Earnings Surprises

Recent Analyst Actions

Jul 30, 2026HSBC
HSBC downgrades Procter & Gamble to Hold after 'weak' Q4
Target:$149.00
+2.0%from $146.15
Jul 29, 2026HSBC
Procter & Gamble downgraded to Hold from Buy at HSBC
Target:$142.00
-2.8%from $146.15
Jul 21, 2026Barclays
Procter & Gamble price target raised to $152 from $146 at Barclays
Target:$152.00
+1.9%from $149.14
Jun 11, 2026Bernstein
Procter & Gamble initiated with a Market Perform at Bernstein
Target:$156.00
+5.2%from $148.32
Apr 27, 2026UBS
Procter & Gamble price target raised to $172 from $166 at UBS
Target:$172.00
+15.9%from $148.47
Apr 27, 2026Deutsche Bank
Procter & Gamble price target raised to $163 from $162 at Deutsche Bank
Target:$163.00
+9.7%from $148.63
Apr 27, 2026Evercore ISI
Procter & Gamble price target lowered to $162 from $170 at Evercore ISI
Target:$162.00
+9.4%from $148.11
Apr 27, 2026Wells Fargo
Procter & Gamble price target raised to $164 from $158 at Wells Fargo
Target:$164.00
+10.7%from $148.11
Apr 14, 2026Barclays
Procter & Gamble price target lowered to $146 from $155 at Barclays
Target:$146.00
+1.5%from $143.86
Apr 9, 2026RBC Capital
Procter & Gamble price target lowered to $167 from $172 at RBC Capital
Target:$167.00
+13.9%from $146.66
Apr 8, 2026Piper Sandler
Procter & Gamble price target lowered to $142 from $150 at Piper Sandler
Target:$142.00
-2.0%from $144.90
Feb 17, 2026Wells Fargo
Procter & Gamble price target raised to $177 from $165 at Wells Fargo
Target:$177.00
+10.6%from $160.07
Jan 23, 2026UBS
Procter & Gamble price target raised to $170 from $161 at UBS
Target:$170.00
+12.5%from $151.06
Jan 23, 2026Wells Fargo
Procter & Gamble price target raised to $165 from $158 at Wells Fargo
Target:$165.00
+10.1%from $149.93
Jan 16, 2026Barclays
Procter & Gamble price target raised to $155 from $151 at Barclays
Target:$155.00
+7.4%from $144.37
Jan 14, 2026UBS
Procter & Gamble price target lowered to $161 from $176 at UBS
Target:$161.00
+9.9%from $146.54
Jan 7, 2026Piper Sandler
Procter & Gamble assumed with a Neutral at Piper Sandler
Target:$150.00
+7.2%from $139.91
Jan 5, 2026Wells Fargo
Procter & Gamble price target lowered to $158 from $170 at Wells Fargo
Target:$158.00
+12.8%from $140.03
Dec 16, 2025Jefferies
Procter & Gamble upgraded to Buy from Hold at Jefferies
Target:$179.00
+23.3%from $145.21
Dec 8, 2025Barclays
Procter & Gamble price target lowered to $151 from $153 at Barclays
Target:$151.00
+5.3%from $143.45
Oct 27, 2025Morgan Stanley
Procter & Gamble price target lowered to $175 from $180 at Morgan Stanley
Target:$175.00
+15.5%from $151.46
Oct 8, 2025UBS
Procter & Gamble price target lowered to $176 from $180 at UBS
Target:$176.00
+16.6%from $150.92
Oct 1, 2025Barclays
Procter & Gamble price target lowered to $153 from $164 at Barclays
Target:$153.00
-0.4%from $153.65
Jul 31, 2025Barclays
Procter & Gamble price target raised to $164 from $161 at Barclays
Target:$164.00
+7.3%from $152.88
Jul 30, 2025UBS
UBS Reiterates Buy Rating on Procter & Gamble (PG)
Target:$180.00
+16.2%from $154.94
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.